Gossamer Bio, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-45.4% -$143M
$172M
Current Assets↓-45.9% -$142M
$168M
Cash & Equivalents↓-18.1% -$8M
$38M
ST Investments↓-60.1% -$149M
$99M
Receivables↑+129.1% +$7M
$12M
Net PPE↑+540.0% +$54K
$64K
Total Liabilities↑+3.2% +$9M
$295M
Current Liabilities↑+40.9% +$18M
$63M
Account Payables↑+157.0% +$4M
$6M
Long-Term Debt
$0
Short-Term Debt
—
Stockholders Equity↓-516.2% -$152M
$-123M
Retained Earnings↓-13.4% -$170M
$-1.44B
Operating Lease ROU Asset↓-19.1% -$978K
$4M
Operating Lease Liability↑+0.0% +$0
$4M
Gross PP&E↑+40.4% +$78K
$271K
Accumulated Depreciation↑+13.1% +$24K
$207K
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Debt Due >Y5
—
Total Debt Carrying Amount
—
Contract Liability↓-11.3% -$6M
$50M
Contract Liability (Current)↑+17.2% +$3M
$20M
Contract Liability (Noncurrent)↓-23.8% -$9M
$30M